IN8BIO, INC. (INAB) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
INAB currently has 9.85M outstanding shares. with significant dilution risk as 260M authorized shares could dilute existing holders by 2636.3%. The company has significantly diluted shareholders by 202.97% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 18, 2026 |
S-3/A filing: This filing is a registration statement (S-3/A) to offer up to $200,000,000 of common stock, preferred stock, debt securities, warrants, rights, and units. |
9.8M | 260M |
| May 07, 2026 |
10-Q filing | 9.8M shares outstanding |
9.8M | 130M |
| Jan 20, 2026 |
S-3 filing: This S-3 filing registers 14,384,052 shares of common stock for resale by selling stockholders, which were initially issued in a private placement on December 22, 2025. |
4.5M | 130M |
| Nov 07, 2025 |
S-3 filing: The company is filing a shelf registration statement to offer and sell up to $200,000,000 of any combination of common stock, preferred stock, debt securities, warrants, rights or units. |
4.5M | 110M |
| Nov 06, 2025 |
10-Q filing | 4.5M shares outstanding |
4.5M | 110M |
| Aug 07, 2025 |
10-Q filing | 4.1M shares outstanding |
4.1M | 110M |
| May 07, 2025 |
10-Q filing | 83.5M shares outstanding |
83M | 110M |
| Mar 13, 2025 |
10-K filing | 72.5M shares outstanding |
72M | 110M |
| Nov 12, 2024 |
10-Q filing | 72.5M shares outstanding |
72M | 110M |
| Nov 04, 2024 |
S-3 filing: This S-3 filing registers 55,494,910 shares of common stock for resale by selling stockholders, with the company not receiving any proceeds from the sale of these shares. |
45M | 110M |
| Aug 08, 2024 |
10-Q filing | 45.1M shares outstanding |
45M | 55M |
| May 09, 2024 |
10-Q filing | 43.3M shares outstanding |
43M | 55M |
| Mar 14, 2024 |
10-K filing | 43.3M shares outstanding |
43M | 55M |
| Jan 12, 2024 |
S-3 filing: This S-3 filing relates to the offer and resale of 42,703,475 shares of common stock by selling stockholders. |
32M | 55M |
| Nov 09, 2023 |
10-Q filing | 31.5M shares outstanding |
32M | 13M |
| Aug 10, 2023 |
10-Q filing | 28.5M shares outstanding |
28M | 13M |
| May 12, 2023 |
10-Q filing | 29.8M shares outstanding |
30M | 13M |
| Mar 30, 2023 |
10-K filing | 24.9M shares outstanding |
25M | 13M |
| Nov 10, 2022 |
S-3 filing: The filing is for a shelf registration allowing the company to offer and sell up to $200,000,000 of common stock, preferred stock, and debt securities from time to time. It also includes an at-the-market offering of common stock up to $7,200,000 through sales agents. |
25M | 13M |
| Nov 10, 2022 |
10-Q filing | 24.5M shares outstanding |
25M | 13M |
| Aug 12, 2022 |
10-Q filing | 18.8M shares outstanding |
19M | 8.8M |
| Aug 09, 2022 |
S-1/A filing: The company is offering shares of common stock and pre-funded warrants. |
19M | 8.8M |
| Aug 08, 2022 |
S-1 filing: This S-1 filing outlines an offering of common stock and pre-funded warrants, with the pre-funded warrants intended for investors who may face ownership restrictions. |
19M | 6.7M |
| May 12, 2022 |
10-Q filing | 18.8M shares outstanding |
19M | 4.6M |
| Mar 17, 2022 |
10-K filing | 18.8M shares outstanding |
19M | 4.6M |
| Nov 10, 2021 |
10-Q filing | 18.8M shares outstanding |
19M | 4.6M |
| Sep 10, 2021 |
10-Q filing | 18.8M shares outstanding |
19M | 4.6M |
| Jul 22, 2021 |
S-1/A filing: This is the initial public offering of common stock of IN8bio, Inc. We are selling 4,000,000 shares of our common stock in this offering. |
N/A | 4.6M |
| Jul 20, 2021 |
S-1/A filing: This is the initial public offering of common stock of IN8bio, Inc. |
N/A | 0 |
| May 07, 2021 |
S-1/A filing: IN8bio, Inc. is offering common stock in an initial public offering. The initial public offering price is expected to be between a specified range per share. |
N/A | 0 |
| Mar 31, 2021 |
S-1/A filing: This is an S-1/A filing for the initial public offering of common stock of IN8bio, Inc. |
N/A | 0 |